<DOC>
	<DOCNO>NCT00630396</DOCNO>
	<brief_summary>The primary aim study find 4 different dos minocycline safe well tolerate know optimal dose test future patient .</brief_summary>
	<brief_title>Study Neuroprotective Drug Limit Extent Damage From Ischemic Stroke</brief_title>
	<detailed_description>Minocycline widely use antibiotic approve Food Drug Administration ( FDA ) treatment infection acne . However , doctor know whether minocycline work stroke patient . Its use stroke patient experimental . There lot information experimental stroke study animal minocycline lessens damage stroke animal recover well . Since minocycline generally safe drug human lot side effect , investigator Georgia Health Sciences University ( formerly Medical College Georgia ) believe might safe effective drug improve outcome patient stroke .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>18 year age acute onset focal neurologic deficit consistent acute ischemic stroke , compute tomographic scan consistent acute cerebral ischemia onset symptom less 6 hour measurable neurologic deficit ( National Institutes Health [ NIH ] Stroke Scale &gt; /= 1 ) allergy tetracycline antibiotic woman childbearing potential know hepatic and/or renal insufficiency Thrombocytopenia history intolerance minocycline dizziness time stroke past month ( selfreport ) aphasia likely interfere patient ability report adverse effect previous functional disability stuporous comatose presence another serious illness likely confound study unlikely available 90 day followup severe stroke ( National Institutes Health [ NIH ] Stroke Scale &gt; 22 ) undergo interventional neuroradiological intervention first 12 hour</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>stroke</keyword>
	<keyword>ischemic</keyword>
	<keyword>neuroprotection</keyword>
	<keyword>minocycline</keyword>
	<keyword>tissue plasminogen activator ( tPA )</keyword>
	<keyword>biomarkers</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>antiapoptotic</keyword>
	<keyword>anti-inflammatory</keyword>
	<keyword>treatment</keyword>
	<keyword>matrix metalloproteinase-9 ( MMP-9 )</keyword>
	<keyword>thrombolysis</keyword>
	<keyword>Minocycline Improve Neurologic Outcome Stroke ( MINOS )</keyword>
	<keyword>cerebrovascular stroke</keyword>
	<keyword>cerebrovascular accident</keyword>
	<keyword>cerebral stroke</keyword>
	<keyword>cerebrovascular accident ( CVA )</keyword>
</DOC>